Skip to content

Clinical trials

Completed Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Completed Clear all

240 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20033
20041
20053
20063
20075
20086
20095
20105
20116
201210
201315
201414
20158
201616
201725
20188
201911
202022
202116
202217
202322
20246
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed240

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim15
Assiut University5
Duke University5
Actelion4
Celgene4
National Heart, Lung, and Blood Institute (NHLBI)4
Post Graduate Institute of Medical Education and Research, Chandigarh4
Royal Brompton & Harefield NHS Foundation Trust4
United Therapeutics4
Weill Medical College of Cornell University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial240
Idiopathic Pulmonary Fibrosis45
Pulmonary Disease, Chronic Obstructive34
Pulmonary Fibrosis30
Hypertension, Pulmonary16
Lung Diseases15
Sarcoidosis15
Dyspnea14
Heart Failure13
Asthma11

Trials

Showing 1 to 25 of 240. Each trial links to its page on Pharma Observatory.

140 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.